Guangdong Zhongsheng Pharmaceutical Co., Ltd.
002317
Rang in aandelen
#4568
Guangdong Zhongsheng Pharmaceutical Co., Ltd. is a Chinese pharmaceutical... Guangdong Zhongsheng Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company actively involved in the entire lifecycle of drug development, from research and development to manufacturing and commercialization. Its product portfolio encompasses both traditional Chinese medicines (TCM) and modern chemical pharmaceuticals. The company's robust research and development initiatives are directed towards creating solutions for a wide array of health conditions, specifically targeting ophthalmological, cardiovascular, cerebrovascular, respiratory, digestive, diabetic, oncological, and age-related degenerative diseases. Established in 1979, the company maintains its primary operations from its headquarters in Dongguan, China.
Aandeelprijs
$3.89
Marktkapitalisatie
$3.30B
Verandering (1 dag)
-3.14%
Verandering (1 jaar)
43.11%
Land
CN
Handel Guangdong Zhongsheng Pharmaceutical Co., Ltd. (002317)
Categorie
Healthcare
EPS voor Guangdong Zhongsheng Pharmaceutical Co., Ltd. (002317)
EPS per June 2026 TTM: $0.04
Volgens de laatste financiële rapporten en de aandelenkoers van Guangdong Zhongsheng Pharmaceutical Co., Ltd. is de huidige EPS van het bedrijf (TTM) $0.04. Eind 2024 had het bedrijf een EPS van $-0.05, een daling ten opzichte van de EPS van 2023 die $0.05 bedroeg.
EPS-geschiedenis van Guangdong Zhongsheng Pharmaceutical Co., Ltd. van 2006 tot 2026
EPS aan het einde van elk jaar
| Jaar | EPS | Wijzigen |
|---|---|---|
| 2026 (TTM) | $0.04 | -28.20% |
| 2025 | $0.05 | -195.74% |
| 2024 | $-0.05 | -209.07% |
| 2023 | $0.05 | -22.07% |
| 2022 | $0.06 | 5.26% |
| 2021 | $0.06 | -167.94% |
| 2020 | $-0.08 | -241.29% |
| 2019 | $0.06 | -26.88% |
| 2018 | $0.08 | -1.75% |
| 2017 | $0.08 | 0.88% |
| 2016 | $0.08 | 25.52% |
| 2015 | $0.06 | 26.20% |
| 2014 | $0.05 | 16.55% |
| 2013 | $0.04 | 6.98% |
| 2012 | $0.04 | 20.42% |
| 2011 | $0.03 | 21.98% |
| 2010 | $0.03 | -1.80% |
| 2009 | $0.03 | 35.61% |
| 2008 | $0.02 | 91.59% |
| 2007 | $0.01 | 42.67% |
| 2006 | $0.01 | 0.00% |
EPS van vergelijkbare bedrijven of concurrenten
| Bedrijf | EPS | EPS-verschil | Land |
|---|---|---|---|
| $6.55 | 18,137.33% |
DE
|
|
| $6.12 | 16,948.47% |
DE
|
|
| $0.72 | 1,914.21% |
JP
|
|
| $3.66 | 10,094.99% |
CH
|
|
| $0.53 | 1,386.63% |
IN
|
